Skip to content

Clinical trials

Phase 2 Cholangiocarcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 2 Country / region: United States Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20041
20061
20071
20093
20111
20132
20145
20157
20162
20177
20186
20196
20207
20219
20223
20236
20247
20253
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Terminated16
Recruiting16
Active, not recruiting12
Withdrawn2
Unknown status2
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)16
Memorial Sloan Kettering Cancer Center4
M.D. Anderson Cancer Center3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
Hoffmann-La Roche2
Massachusetts General Hospital2
Stanford University2
Washington University School of Medicine2
Abramson Cancer Center at Penn Medicine1
Aiwu Ruth He, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma88
Gallbladder Neoplasms26
Bile Duct Neoplasms18
Biliary Tract Neoplasms14
Carcinoma, Hepatocellular14
Colorectal Neoplasms12
Liver Neoplasms10
Ovarian Neoplasms8
Pancreatic Neoplasms8
Neoplasm Metastasis7

Trials

Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.